Department of Error

Guidice LC, As-Sanie S, Arjona Ferreira JC, et al. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet 2022; 399: 2267–79—In this Article, the sixth sentence of the third paragraph of the Results section should have referenced table 2 (not table 3). This correction has been made to the online version as of Aug 25, 2022.